Weshalb die Coherus Biosciences-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 05. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2019 | 7,52 | 15,95 | 112,10% |
| 2 | 2015 | 13,19 | 21,29 | 61,41% |
| 3 | 2016 | 21,29 | 26,35 | 23,77% |
| 4 | 2021 | 13,76 | 15,00 | 9,01% |
| 5 | 2018 | 7,34 | 7,52 | 2,45% |
| 6 | 2025 | 1,41 | 1,44 | 2,13% |
| 7 | 2020 | 15,95 | 13,76 | -13,73% |
| 8 | 2024 | 2,98 | 1,41 | -52,68% |
| 9 | 2022 | 15,00 | 6,75 | -55,00% |
| 10 | 2023 | 6,75 | 2,98 | -55,85% |
| 11 | 2017 | 26,35 | 7,34 | -72,14% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2017 | 26,35 | 7,34 | -72,14% |
| 2 | 2023 | 6,75 | 2,98 | -55,85% |
| 3 | 2022 | 15,00 | 6,75 | -55,00% |
| 4 | 2024 | 2,98 | 1,41 | -52,68% |
| 5 | 2020 | 15,95 | 13,76 | -13,73% |
| 6 | 2025 | 1,41 | 1,44 | 2,13% |
| 7 | 2018 | 7,34 | 7,52 | 2,45% |
| 8 | 2021 | 13,76 | 15,00 | 9,01% |
| 9 | 2016 | 21,29 | 26,35 | 23,77% |
| 10 | 2015 | 13,19 | 21,29 | 61,41% |
| 11 | 2019 | 7,52 | 15,95 | 112,10% |